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Abstract
The infection of viruses to a neighboring cell is considered to be beneficial in terms of evasion from host anti-virus defense
systems. There are two pathways for viral infection to ‘‘right next door’’: one is the virus transmission through cell-cell fusion
by forming syncytium without production of progeny virions, and the other is mediated by virions without virus diffusion,
generally designated cell-to-cell transmission. Influenza viruses are believed to be transmitted as cell-free virus from infected
cells to uninfected cells. Here, we demonstrated that influenza virus can utilize cell-to-cell transmission pathway through
apical membranes, by handover of virions on the surface of an infected cell to adjacent host cells. Live cell imaging
techniques showed that a recombinant influenza virus, in which the neuraminidase gene was replaced with the green
fluorescence protein gene, spreads from an infected cell to adjacent cells forming infected cell clusters. This type of virus
spreading requires HA activation by protease treatment. The cell-to-cell transmission was also blocked by amantadine,
which inhibits the acidification of endosomes required for uncoating of influenza virus particles in endosomes, indicating
that functional hemagglutinin and endosome acidification by M2 ion channel were essential for the cell-to-cell influenza
virus transmission. Furthermore, in the cell-to-cell transmission of influenza virus, progeny virions could remain associated
with the surface of infected cell even after budding, for the progeny virions to be passed on to adjacent uninfected cells.
The evidence that cell-to-cell transmission occurs in influenza virus lead to the caution that local infection proceeds even
when treated with neuraminidase inhibitors.
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Introduction
It is generally accepted that viruses, released as cell-free virions
from an infected cell, transmit to distant cells and tissues. This
spreading pathway contributes to wide-ranged diffusion of cell-free
viruses. However, in this spreading pathway, viruses are exposed
to host anti-virus defense systems. In contrast, direct infection to a
neighboring cell is considered to be beneficial for the virus in terms
of evasion from the host anti-virus defense. There are two typical
manners in infection to ‘‘right next door’’: one is the virus
transmission through cell-cell fusion by forming syncytium without
production of progeny virions, and the other is mediated by virions
without virus diffusion, generally designated cell-to-cell transmis-
sion [1,2].
The cell-cell fusion infection pathway is characteristic for a
variety of virus such as paramyxoviruses, herpesviruses, some
retroviruses, and so on. For example in the case of measles virus
belonging to Paramyxoviridae, infection is initiated by the interaction
of the viral hemagglutinin glycoprotein with host cell surface
receptors. The virus penetrates into the cell through membrane
fusion mediated by the interaction of the fusion glycoprotein. In
later stages of infection, newly synthesized glycoproteins accumu-
late at the cell membrane resulting in fusion of the infected cell
with neighboring cells by producing syncytia. Thus, viruses can
spread from cell to cell without producing cell-free virus particles.
The examples of the cell-to-cell transmission are diverse, and
these mechanisms are dependent on pairs of viruses and host cells.
Vaccinia virus particles bound on the filopodium of an infected
cell are repelled toward neighboring uninfected cells by the
formation of filopodia using actin filament [3]. The filopodia direct
viruses to uninfected cells. Immunotropic viruses including
retroviruses utilize an immunological synapse, designed as
virological synapses for the cell-to-cell transmission [4–7].
Claudin-1 and occludin, components of tight junction, are
involved in hepatitis C virus (HCV) entry through the cell-to-cell
transmission [8,9]. The cell-to-cell transmission through tight
junction is also observed in other viruses which infect epithelial
layers [10,11]. These retroviruses and HCV remain on the surface
of an infected cell even after budding. The uninfected cells
adjacent to these infected cells can accept or take over viruses from
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28178the infected cell. Thus, the cell-to-cell transmission can be
categorized into two manners based on the state of infecting
viruses, either cell-free or cell-associated virions.
Influenza virus, belonging to the family of Orthomyxoviridae, is one
of the most serious zoonotic pathogens and causes seasonal
epidemics or periodic pandemics among human beings around the
world. The viral envelope consists of a lipid bilayer derived from
cells that anchors three of viral transmembrane proteins,
hemagglutinin (HA), neuraminidase (NA), and matrix protein 2
(M2). Influenza virus infection is initiated by the attachment of HA
on virus particles to cell surface receptors containing sialic acids
[12]. It has been known that the specific interaction between HA
and sialic acid species is one of the determinants of the host range
of influenza viruses [13]. Beside its role in the viral attachment,
HA is also involved in intracellular fusion between viral envelope
and host cell endosome membrane in the endocytotic pathway, by
which the virus content is released inside the host cell [14]. The
functional maturation of HA is mediated by the cleavage of HA
into two disulfide-linked glycopolypeptides, HA1 and HA2 [15],
accomplished by trypsin or trypsin-like proteases derived from host
cells [16–19]. The membrane fusion is induced by a conforma-
tional change in the mature HA, which is triggered at low pH in
the endosome, allowing viral ribonucleoprotein complexes to
release into the cytoplasm [20,21]. Thus, HA plays a critical role
in initiation and progression of influenza virus infection. Influenza
virus NA possesses the enzymatic activity that cleaves a-ketosidic
linkages between terminal sialic acids and adjacent sugar residues
of cellular glycoconjugates [22]. The sialidase activity of NA
removes terminal sialic acid residues from HA and NA proteins as
well as host cell surface glycoproteins. Since the terminal sialic acid
of sialyloligosaccharides is critical for HA binding, the receptor-
destroying activity of NA serves to counter the receptor-binding
activity of HA. It is quite likely that this activity contributes to
prevention of successive superinfection of an infected cell [23]. In
the absence of the functional sialidase activity, progeny virions
aggregate on the cell surface due to the HA receptor-binding
activity and can not be released [24,25]. Thus, NA cleaves sialic
acids from the cell surface and facilitates virus release from
infected cells. However, it is not clear whether every progeny
virion is released as cell-free virion to infect the uninfected cells after
diffusion into the extracellular environment. Influenza viruses are
generally transmitted as cell-free viruses from infected to uninfected
cell but they may also infect through the cell-to-cell transmission,
in particular during local lesion formation.
Here, we examined whether influenza virus transmits from an
infected cell to adjacent uninfected cells without virus release. Live
cell imaging techniques showed that a recombinant influenza
virus, in which the NA gene was replaced with the green fluorescence
protein gene, spreads from an infected cell to adjacent cells forming
infected cell clusters. Furthermore, progeny virions remain
associated on the surface of infected cell even after budding, and
then progeny virions could be passed to adjacent uninfected cells.
Results
Influenza virus can spread in an NA-independent manner
to adjacent cells
To examine the transmission pathway of influenza virus, we
performed immunofluorescence analyses by using anti-nucleopro-
tein (NP) polyclonal antibody. Influenza virus can form an
infection center even in the presence of oseltamivir, a potent NA
inhibitor (commercially known as Tamiflu) [26–28]. Oseltamivir
at the concentration of 50 mg/ml completely prevented the release
of progeny influenza viruses (Figure 1A). Noted that a large
number of single fluorescent foci caused by initial infection
markedly expanded and formed cell clusters consisting of 5–10
infected cells in an MDCK cell monolayer (Figures 1B and S1),
suggesting influenza virus can spread to some extent in the
presence of oseltamivir. To verify that NA is not involved in this
spreading, we generated an NA-deficient influenza virus by a
reverse genetics method as described previously [29,30]. The NA-
deficient influenza virus contains a mutated NA segment, in which
the NA coding region including a sialidase catalytic domain was
replaced with the enhanced green fluorescent protein (EGFP) gene [29].
By this replacement, the NA activity is eliminated from the
recombinant influenza virus, and EGFP can be utilized as a marker
for viral infections. Immunofluorescence analyses demonstrated
that the NA-deficient influenza virus also forms infected cell
Figure 1. Influenza viruses can spread independent of the NA
activity. (A) MDCK cells were infected with influenza virus A/WSN/33 at
a multiplicity of infection (MOI) of 0.001 PFU per cell. At 48 hours post
infection (hpi), culture supernatant was collected, and then its virus titer
was determined by plaque assays. Each result was represented by a
value relative to that in the absence of the drug. Error bars indicate
standard deviation (s.d.) from 3 independent experiments. (B) Confluent
MDCK cells were infected by wild-type influenza virus A/WSN/33 or NA-
deficient influenza virus at MOI of 0.0001 in the presence or absence of
50 mg/ml oseltamivir phosphate. NA-deficient influenza virus was
generated by reverse genetics as previously described [29]. After
incubation at 37uC for 36 hours, immunofluorescence analyses were
performed using anti-nucleoprotein (NP) polyclonal antibody and anti-
rabbit IgG antibody conjugated to Alexa Fluor 568 (Invitrogen). Scale
bar, 100 mm.
doi:10.1371/journal.pone.0028178.g001
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the presence of oseltamivir (Figure 1B). The fluorescence pattern
of NP overlapped with the localization of GFP derived from the
EGFP gene of the NA-deficient influenza virus (Figure S2). Thus,
NA-deficient influenza virus can be used to investigate the NA-
independent infection pathway of influenza virus.
Next, we performed live cell imaging analyses to directly
observe the infection time course of the NA-deficient influenza
virus. The GFP fluorescence derived from the NA-deficient
influenza virus first appeared in a single cell on an MDCK cell
monolayer at 24 hours post infection. The virus started to spread
from an infected cell to adjacent cells in 5–6 hours after the first
appearance of a GFP-positive cell (Figure 2 and Video S1). The
spreading rate was clearly faster than the rate of cell divisions. The
mean doubling time of uninfected MDCK cells was 20–24 hours
under the condition employed here, and it is expected that the
proliferation speed would be much slowly because infected
MDCK cells were maintained in the serum-free medium and
formed cell monolayer at the high cell density. These suggest that
NA-deficient influenza viruses may infect adjacent cells through
the cell-to-cell transmission mechanism without apparent produc-
tion of cell-free virions.
Cell-to-cell transmission pathway of influenza viruses is
less sensitive to neutralizing antibody
The cell-to-cell virus transmission pathway could be interpreted
as one of viral evolving strategies to avoid neutralizing antibody
responses [2,31,32]. Therefore, we examined the effect of
neutralizing antibody on NA-deficient influenza virus. A poly-
clonal antibody with the neutralizing activity against influenza
virus particles inhibited infection of cell-free viruses to less than 50%
at the concentration of 0.03%, although the cell cluster formation
was observed at the concentration less than 0.01%. On the other
hand, the NA-independent transmission of the NA-deficient
influenza virus was blocked only when neutralizing antibody was
present at the concentration of 0.3% (Figure 3). These results
indicated that the NA-independent transmission of influenza
viruses is less sensitive to the neutralizing antibody.
NA-independent transmission of influenza virus is HA-
dependent
Next, to investigate the mechanism of NA-independent
transmission of influenza virus, we examined whether HA is
involved in this transmission. In the absence of the NA activity,
virus spreading from an infected cell to adjacent cells was
dramatically suppressed by omission of trypsin, essential for
maturation of HA, from the experimental condition (Figure 4A).
The GFP fluorescence derived from NA-deficient influenza virus
appeared in a single cell at 24 hours post infection. However, this
virus did not spread, but rather disappeared during subsequent
24 hours (Video S2). These observations indicate that the NA-
independent cell-to-cell transmission of influenza virus is depen-
dent on HA maturation mediated by trypsin, as is the case for the
general cell-free transmission of this virus.
To clarify whether virus particles or viral RNP complexes are
transmitted to adjacent cells, we examined the effect of
amantadine on the cell-to-cell transmission of influenza virus.
Amantadine inhibits the early step of uncoating of influenza virus
RNP from virion in endosomes [33,34]. For this study, other
influenza virus strain, influenza virus A/Udorn/72, was used
instead of influenza virus A/WSN/33 because influenza virus A/
WSN/33 is highly resistant to amantadine [35]. We confirmed
that influenza virus A/Udorn/72 is sensitive to oseltamivir (Figure
S3) and could also spread via cell-to-cell transmission independent
of the NA activity as did for influenza virus A/WSN/33
(Figures 1B and 4B). In the case of a single administration of
amantadine, fluorescent foci derived from infected cells scattered,
and the number of single foci was greatly decreased compared
Figure 2. NA-deficient influenza virus spreads through cell-to-cell transmission. Confluent MDCK cells were infected with the NA-deficient
influenza virus at MOI of 0.0001. After incubation at 37uC for 24 hours, a single GFP-positive cell, in which the recombinant virus replicated, was found
at 1 hour after starting monitoring, and then this cell and its neighborhood were traced during the period from 24 hpi to 48 hpi at interval of 1 hour.
Scale bar, 50 mm.
doi:10.1371/journal.pone.0028178.g002
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administration of oseltamivir, fluorescent foci formed some clusters
and expanded in a time-dependent manner (Figure 4B). This
dissimilarity of inhibitory manner was caused by the difference of
the sites of action between amantadine and oseltamivir. Aman-
tadine inhibits the replication of influenza A virus by preventing
the translocation of vRNP complexes from endosomes to the
cytoplasm, whereas oseltamivir has no effects on viral replication
itself but inhibits the release of cell-free virions from infected host
cells. We investigated the inhibitory effect of amantadine on the
cell-to-cell transmission of influenza viruses. The formation of
infected cell clusters was observed with co-administration of
amantadine and oseltamivir, as well as with a single administration
of oseltamivir (Figure 4B). However, the quantitative analysis
revealed that the size of infected cell clusters with the co-
administration were decreased as compared to that with
oseltamivir alone (Figure 4C). These observations indicated that
the NA activity-independent cell-to-cell transmission of influenza
virus was susceptible to the inhibitory effect of amantadine,
suggesting that the cell-to-cell transmission undergoes through
endocytosis but vRNP complex itself is not incorporated in the
infected cells by adjacent cells.
Cell-to-cell transmission occurs on the apical cell
membrane
The virus transmission undergoes from infected to uninfected
cells through either basolateral [36–38] or apical [39–42] sides. In
the case of influenza virus, cell-free progeny virions are released
only from the apical surface of polarized epithelial cells [43]. This
releasing polarity is achieved by directed transport of viral
membrane proteins to the apical plasma membrane [44]. Indeed,
that HA and NA glycoproteins are associated with lipid rafts, and
the raft association has been implicated in apical transport [45,46].
To determine whether or not the cell-to-cell transmission of the
NA-deficient influenza virus occurs on the apical surface, we
performed transwell assays in the presence of the neutralizing
antibody to influenza A viruses. The neutralizing antibody was
added to infected MDCK cell monolayer from apical or
Figure 3. The cell-to-cell transmission of the NA-deficient influenza virus is less sensitive to the neutralizing antibody. (A) Infection of
the wild-type and (B) NA-deficient influenza virus were performed in the presence or absence of antiserum containing neutralizing antibodies.
Immunofluorescence analyses were performed with cells infected with wild-type influenza virus at 18 hpi using anti-NP antibody and anti-rabbit IgG
antibody conjugated to Alexa Fluor 488 (Invitrogen). GFP fluorescence derived from the recombinant virus was observed at 36 hpi. Scale bar, 100 mm.
(C) The level of viral spreading was indicated in the graph by measuring NP and GFP derived from wild-type and NA-deficient virus, respectively. Five
different microscope fields were taken randomly, and then the intensity of green color was analyzed with ImageJ NIH image processing software.
Each result was represented by a value relative to that in the absence of neutralizing antibodies. Error bars indicate s.d. from 3 independent
experiments.
doi:10.1371/journal.pone.0028178.g003
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fluorescence derived from the recombinant virus was examined.
Addition of high concentrations of the neutralizing antibody from
the apical side blocked the cell-to-cell transmission of the NA-
deficient influenza virus, whereas the addition from the basolateral
side had no effect (Figure 5). These observations indicated that the
polarity in the influenza virus budding in the cell-to-cell
transmission pathway is apical.
Influenza viruses can not re-infect previously infected
cells
Previous report showed that influenza viruses were refractory to
superinfection with a second cell-free virus [23]. In the case of the
cell-to-cell transmission of influenza virus in the presence of
oseltamivir, it is possible that a progeny virion is temporarily
bridged by HA between an infected cell and adjacent uninfected
cells, since viruses can not be released from infected cell surface
due to the inhibition of the NA activity by oseltamivir. The cell-
associated progeny virion may have an opportunity to re-infect the
previously infected cell, compared to a cell-free progeny virion in
the general spreading. Thus, we examined whether influenza
viruses can infect the cell which had already been infected, using
ts53 mutant and wild-type influenza virus A/WSN/33. ts53 virus
has a substitution mutation from U to C at the nucleotide position
of 701 in the PA gene. This substitution introduces an amino acid
change from wild-type Leu 226 to Pro 226 and gives a defect in
the viral genome replication process [47,48]. At first, cells were
infected with ts53 virus at moi of 10, and after incubation for 0, 2,
4, 6, and 8 hours, cells were superinfected with wild-type virus at
moi of 10. The amount of segment 3 viral RNA (vRNA) encoding
PA was determined quantitatively by RT-PCR. Then, using a
mutated primer for PCR, we could introduce a Stu I site only in
the PCR products derived from the wild-type sequence (Figure 6A).
Thus, DNA fragments amplified from the wild-type and ts53 could
be distinguished by Stu I digestion. The digested DNA fragments
containing 220 and 199 base pairs derived from ts53 and wild-
type, respectively, were separated through PAGE. After 6 hours or
later post infection, re-infection with the second challenging virus
hardly occurs in the absence of oseltamivir. However, in the
presence of oseltamivir, appearance of wild-type fragment suggests
that the re-infection had occurred (Figure 6B). The result indicates
Figure 4. The cell-to-cell transmission of the NA-deficient influenza virus requires functional HA. (A) Confluent MDCK cells were infected
with the NA-deficient influenza virus at MOI of 0.0001 in the presence or absence of 1 mg/ml trypsin. GFP fluorescence derived from the recombinant
virus was observed at 36 hpi. Scale bar, 100 mm. (B) MDCK cells were infected with influenza virus A/Udorn/72 at moi of 0.0001 in the presence or
absence of 50 mM amantadine or 50 mg/ml oseltamivir phosphate. Amantadine at the concentration of 50 mM almost completely inhibited the
production of progeny virions (data not shown). After incubation for 12, 24, and 48 h, immunofluorescence analyses were performed using anti-NP
antibody and anti-rabbit IgG antibody conjugated to Alexa Fluor 488 (Invitrogen). Viral NP and nuclear DAPI staining are shown in green and blue,
respectively. Scale bar, 100 mm. (C) Median sizes of clusters were shown as box plots summarizing sizes of 60 individual infectious foci formed in the
presence of oseltamivir alone, or both oseltamivir and amantadine. Immunofluorescence analyses were performed as described in (B) at 24 hpi. Boxes
enclose the lower and upper quartiles; thick horizontal lines represent the median; dashed lines indicate the extreme values; and black dots are
outliers of individual infectious foci. The size of infectious foci was measured with AxioVision Release 4.7.2 imaging software (Carl Zeiss). Median sizes
shown in red letters were clearly different from each other (p,0.01).
doi:10.1371/journal.pone.0028178.g004
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even after budding, and can infect the cell previously infected, as
well as uninfected cells adjacent to the infected cell, when
oseltamivir is present.
Discussion
With the except for the virus which spreads through the cell-cell
fusion transmission, virus infection is initiated by the binding of
cell-free virions to their host cells. Recently, the virus transmission
mechanism from an infected cell to adjacent cells without virus
diffusion into the extracellular environment is highlighted from the
aspect of its significance in virus spreading in the presence of
antibodies [1,2]. This antibody-insensitive pathway is often called
cell-to-cell transmission [2]. The cell-to-cell transmission may be
categorized into two pathways, i.e., transmission of cell-free virions
to adjacent uninfected cells, and transmission of progeny virions
associated on the surface of an infected cell even after budding
through narrow synaptic space between an infected cell and
adjacent uninfected cells. As an example of the former mechanism,
cell-free vaccinia virus particles associated with the filopodium of an
infected cell are repelled toward neighboring uninfected cells by
inducing the formation of actin filament [3]. Several cases have
been reported for the latter mechanism: Immunotropic viruses
including retroviruses utilize the immunological synapses [4–7].
Immune cells are not constitutively polarized, but contain the
machinery that directs their secretory apparatus towards a cell that
is involved in an immunological synapse. This machinery can be
subverted by retroviruses containing human immunodeficiency
virus (HIV). An HIV-infected cell can polarize viral budding
towards a target cell expressing receptor through a structure called
a virological synapse. Virions bud from an infected cell into a
synaptic cleft, from which they fuse with the target-cell plasma
membrane [49–52]. The progeny virions of HCV are trapped
between infected and uninfected cell membranes at the tight
junction. Using Claudin-1 known as a component of the tight
junction and one of the entry factors of HCV [8], virions fuse with
and penetrate uninfected target cells [31]. Therefore, HCV may
acquire the ability to spread within polarized liver epithelium.
Thus, the cell-to-cell transmission certainly plays significant roles
for the dissemination of several enveloped viruses. However, the
cell-to-cell transmission of influenza virus has not been discussed
well. Here, we have shown that influenza virus spreads by forming
infected cell clusters even in the presence of an NA inhibitor. Live
cell imaging clearly showed that influenza virus lacking the NA
activity spreads from an infected cell to adjacent cells through the
cell-to-cell transmission mechanism (Figure 2). This was also the
case for wild-type influenza virus during early phases of infection
(Figure 4B). In the cell-to-cell transmission of influenza virus,
progeny virions could remain associated with the surface of
infected cell even after budding, and then these progeny virions
can be passed on to adjacent uninfected cells.
We showed that the cell-to-cell transmission of the NA-deficient
influenza virus depends on functional HA. The viral spreading was
dramatically suppressed without HA activation by trypsin treatment
(Figure 4A). Moreover, the cell-to-cell transmission was also blocked
by amantadine, which inhibits the acidification of endosomes
required for uncoating of influenza virus particles in endosomes
[33,34]. These findings indicate that functional HA and endosome
acidification by M2 ion channel are required for the cell-to-cell
influenza virus transmission, thereby allowing viruses to enter the
adjacent cells through the endocytotic pathway (Figure 4).
Our findings showed that the NA-deficient influenza virus is not
diffused into the extracellular environment. The viral spreading in
the absence of oseltamivir appears to be much faster compared to
the viral spreading in the presence of the drug, suggesting that NA
could be involved in determination of spreading speed (Figure 4B).
The NA activity prevented progeny virions from entering cells
which virus came from (Figure 6), implying that progeny virus
particles should be transmitted to adjacent uninfected cells. The
cell-to-cell transmission started in early phase of infection, and the
virus spread through diffusion of cell-free viruses (Figure 4B).
Indeed, it was reported that the cell-to-cell transmission is a rapid
spreading pathway in the case of vaccinia virus [3]. Vaccinia virus
induces a blocking mechanism of superinfection and thereby
infects to adjacent uninfected cells efficiently. In early phases of
vaccinia virus infection, viral proteins A33 and A36 are expressed
at the infected cell surface. Once cell-free virus particles contact the
filopodium, the A33/A36 complex induces the formation of actin
filament, which causes this superinfected virion to be repelled
toward uninfected cells [3]. Influenza viruses can re-infect the cells
previously infected in the presence of oseltamivir (Figure 6),
suggesting that a progeny virion may be bridged by HA between
infected and adjacent uninfected cells temporarily. Thus, in the
case of the cell-to-cell transmission of influenza virus, we propose
that progeny virions associated with the surface of infected cells
even after budding are directed to adjacent uninfected cells. The
cell-to-cell transmission mechanism of influenza virus is distinctly
different from that of vaccinia virus in the infecting virus status:
Infected cell-associated virions and cell-free virions are involved in
the cell-to-cell transmission of influenza virus and vaccinia virus,
respectively. The strategy for influenza virus appears to be similar
to that for HCV. HCV progeny virions budded from an infected
cell are trapped between infected and uninfected adjacent cell
membranes at the tight junction. HCV virions then, enter into
adjacent cells through endocytosis and low pH-dependent
membrane fusion using Claudin-1 [8]. The cell-to-cell transmis-
sion of influenza virus also required functional HA and endosome
acidification by M2 ion channel. However, it has not been
reported that HCV has a gene encoding a receptor destroying
Figure 5. The cell-to-cell transmission of the NA-deficient
influenza virus occurs the apical cell surface. Confluent MDCK
cells were prepared in transwell inserts and infected with the NA-
deficient influenza virus at MOI of 0.0001 in the presence or absence of
0.3% (v/v) antiserum containing neutralizing antibodies (nAb) to
influenza A virus. After virus adsorption, the antiserum was added
from apical or basolateral side. GFP fluorescence derived from the
recombinant virus was observed at 36 hpi. The antiserum added from
the apical side could markedly block the cell-to-cell transmission of the
NA-deficient influenza virus, whereas the antiserum added from the
basolateral side could not. Scale bar, 100 mm.
doi:10.1371/journal.pone.0028178.g005
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progeny particles are bridged between infected and adjacent
uninfected cells temporarily like influenza virus in the presence of
oseltamivir. Progeny influenza virus particles could be transmitted
to adjacent uninfected cells efficiently in the presence of the NA
activity, suggesting that the cell-to-cell transmission of influenza
virus is more strategic than that of HCV.
Our findings raise an interesting question as to what is the
biological significance of cell-to-cell transmission for influenza virus
infection in vivo. Until now, it had been believed that influenza virus
was released from infected cells as cell-free virions and then spread
from cell to cell as well as from organism to organism. The
transmission mode by cell-free virions undergoes the extremely high-
speed of its diffusion and causes epidemic or pandemic infection.
The tropism in an infected animal body is generally restricted to
respiratory tract or lung and its periphery, and the requirement of a
trypsin-like protease has been generally described for the reason of
the restriction. It is possible that the cell-to-cell transmission mode
may play a significant role for the virus spreading inside of
organism, although cell-free influenza virions are causative of high-
speed spreading. At the least, the limited but distinct level of
infection followed by replication could provide some opportunity to
generate influenza virus variants. It is an open question whether the
cell-to-cell transmission mode is involved in the pathogenesis caused
by influenza virus infection in vivo.
The existence of cell-to-cell transmission pathway gives a
caution when NA inhibitors are used, because NA inhibitors
may not be sufficient to completely block the spread of influenza
Figure 6. Influenza viruses can not re-infect previously infected cells. (A) A method for determination of the amount of segment 3 genome
derived from ts53 and wild-type. Total RNA was reverse-transcribed with the primer PA-895-rev, which is complementary to the segment 3 positive-
sense RNA. The cDNA was amplified by PCR using primers, PA-895-rev and PA-695-cut partially corresponding to segment 3 positive sense RNA
between the nucleotide sequence positions 678 to 700 except for 696 and 697, which are shown in red letters. Since segment 3 of ts53 has a
substitution mutation from U to C at the nucleotide position of 701, the PCR product derived from wild-type could be digested by Stu I but not that
from ts53. Then, PCR products were digested with Stu I and separated through 8% PAGE. (B) Detection of the genome of the segment 3 derived from
ts53 or wild-type. At 3 hours post superinfection of wild-type virus, total RNA was extracted, and semi-quantitative RT-PCR was performed.
Subsequently, the amplified DNA products were digested with Stu I and separated through 8% PAGE. Large and small fragments derived from ts53
and wild-type viruses were 220 and 199 base pairs, respectively. The relative amount of wild-type segment 3 to that at 0 hour in the absence of
oseltamivir phosphate was shown in the graph. Error bars indicate S.D. from 3 independent experiments. White bar, in the absence of oseltamivir
phosphate; black bar, in the presence of oseltamivir phosphate.
doi:10.1371/journal.pone.0028178.g006
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sion pathway exists, development of antiviral therapeutic strategies
in addition to NA inhibitors is highly recommended.
Materials and Methods
Cells and viruses
Madin-Darby canine kidney (MDCK) cells were kindly gifted
by A. Ishihama (Hosei University), and maintained in minimal
essential medium (MEM) (Nissui) containing 10% fetal bovine
serum. Human embryonic kidney 293T cells were kindly gifted by
Y. Kawaoka (University of Tokyo), and maintained in Dulbecco
modified Eagle medium (DMEM) (Nissui) supplemented with 10%
fetal bovine serum. Influenza virus A/Udorn/72 was grown in
allantoic sacs of 11 day-old embryonated eggs (MIYAKE
HATCHERY). Wild-type influenza virus A/WSN/33 and ts53
mutant were used after single-plaque isolation. MDCK cells were
infected with influenza virus A/WSN/33 or ts53 at a multiplicity
of infection (MOI) of 0.1 PFU/cell, and incubated at 37uC and
34uC, respectively. After incubation for 24 h, the culture fluid was
harvested and centrifuged at 1,7006 g for 10 min. The virus
suspension was stored at 280uC until use.
Antibodies
The production of rabbit polyclonal anti-NP antibody was
described previously [53], and this antibody was used as a primary
antibody for indirect immunofluorescence assay. A goat anti-
rabbit IgG antibody conjugated to Alexa Fluor 488 or Alexa Fluor
568 was purchased from Invitrogen and used as a secondary
antibody for indirect immunofluorescence assay. A polyclonal
antibody against influenza A virus was obtained from 2-month-old
female rabbit immunized with 250 mg of purified virions of
influenza virus strain A/Puerto Rico/8/34 [54]. The generation
of antibodies was boosted three times and used as neutralizing
antibodies to block the influenza virus infection.
Determination of the inhibition effect of oseltamivir on
virus production
MDCK cells were infected with influenza virus A/WSN/33 at a
multiplicity of infection (MOI) of 0.001 PFU per cell. After virus
adsorption at 37uC for 1 hour, the cells were washed with serum-
free MEM and incubated at 37uC with maintenance medium
(MEM containing vitamins and 0.1% BSA) containing oseltamivir.
At 48 hours post infection (hpi), culture supernatant was collected,
and then its viral titer was determined by plaque assays.
Generation of neuraminidase (NA)-deficient viruses
An NA-deficient influenza virus possessing the terminal
sequences of NA segment but lacking the NA coding region,
which was replaced with enhanced green fluorescent protein (EGFP)
gene, was generated by reverse genetics as described previously
[29,30]. For reverse genetics, we used plasmids containing cDNAs
of the influenza virus A/WSN/33 viral genome under the control
of the human RNA polymerase I promoter (referred to as Pol I
plasmids). Briefly, 293T cells were transfected with seven Pol I
plasmids for production of all vRNA segments of influenza virus
A/WSN/33 and one for the mutant NA vRNA segment
containing EGFP ORF, together with protein expression vectors
for PB2, PB1, PA, and NP controlled by the chicken b-actin
promoter (pCAGGS). TransIT-293 (Mirus) was used for transfec-
tion. At 24 hours post transfection, recombinant viruses were
harvested from the cell surface using bacterial NA derived from
Clostridium perfringens (sigma). MDCK cells were infected with
harvested recombinant viruses treated with N-tosyl-L-phenyl-
alanine chloromethyl ketone (TPCK)-trypsin (1 mg/ml). After
confirmation of GFP fluorescence derived from amplified
recombinant virus genomes at 48 hours after infection, the
recombinant viruses on the cell surface were collected using
bacterial NA. The viral titer of recombinant viruses was
determined by counting the number of infected foci using a
fluorescence microscopy (Carl Zeiss).
Indirect immunofluorescence assay
Cells on coverslips were fixed with 4% paraformaldehyde in
phosphate-buffered saline (PBS) for 10 min and permeabilized with
0.2% NP-40 in PBS. The coverslips were soaked in 1% bovine
serum albuminin PBS, and then incubated at roomtemperature for
1 hour with a primary antibody. After being washed twice with
PBS, the coverslips were incubated at room temperature for 1 hour
with a secondary antibody. The coverslips were then incubated at
room temperature for 5 min with 3 mM4 9,69-diamidino-2-
phenylindole (DAPI) and finally mounted on glass plates, and cells
were observed under the fluorescence microscope.
Live cell imaging analyses
Living cells were analyzed using BioStation ID system (GE
Healthcare). Confluent MDCK cells were infected with the NA-
deficient influenza virus at the multiplicity of infection (MOI) of
0.0001 in the presence or absence of 1 mg/ml TPCK-trypsin. At
24 hours post infection, culture dishes containing infected cells
were set into the chamber of BioStaion ID system, which was
maintained at 37uC under 5% CO2 and 95% humidity. Then,
images were acquired during next 24 hours at interval with
1 hour. The excitation wavelength was controlled by a manual
filter wheel equipped with filters suitable for enhanced green
fluorescence protein (EGFP).
Transwell assay
Confluent MDCK cell monolayer was prepared on transwell
inserts (BD Falcon, pore size 0.4 mm) and infected with the NA-
deficient influenza virus at MOI of 0.0001. After virus adsorption at
37uC for 1 hour, the cell monolayer was washed with serum-free
MEM, and maintenance medium was added into both sides within
the transwells. The neutralizing antibody to influenza A virus was
added into the inside or the outside of transwell inserts with the
maintenance medium. Subsequently, cells were incubated at 37uC
for36 hoursfollowedbyanalysesusingthefluorescence microscopy.
RT-PCR
ts53 virus has a substitution mutation from U to C at the
nucleotide position of 701 in the PA gene. This substitution
introduces an amino acid change from wild-type Leu 226 to Pro
226 and gives a defect in the viral genome replication process [48].
However, under the permissive temperature, the level of viral
genome replication is no difference between wild-type and ts53
[47]. To discriminate the genome of wild-type and that of ts53,
total RNA was reverse-transcribed by reverse transcriptase
(TOYOBO) with PA-895-rev (59-TTAATTTTAAGGCATC-
CATCAGCAGG-39), which is complementary to the segment 3
positive sense RNA. The cDNA was amplified by PCR using
primers, PA-895-rev and PA-695-cut (59-TCTCCCGCCA-
AACTTCTCAGGCC-39) partially corresponding to segment 3
positive sense RNA between nucleotide sequence positions 678 to
700 except for nucleotide positions 696 and 697. Since segment 3
of ts53 has a substitution mutation from U to C at the nucleotide
position of 701, the PCR product derived from wild-type was
digested by Stu I but not that from ts53. After PCR reactions, PCR
Cell-to-Cell Transmission of Influenza Virus
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Large and small fragments derived from ts53 and wild-type viruses
were 220 and 199 base pairs, respectively. DNA was stained with
GelRed (BIOTIUM) and visualized by UV illumination.
Supporting Information
Figure S1 Formation of cell cluster caused by initial
infection. MDCK cells were infected with influenza virus A/
WSN/33 at moi of 0.0003 in the presence or absence of 50 mg/ml
oseltamivir phosphate. After incubation for 8 and 24 h, immuno-
fluorescence analyses were performed using anti-NP antibody and
anti-rabbit IgG antibody conjugated to Alexa Fluor 488 (Invitro-
gen). Nuclear DAPI and viral NP staining patterns are shown in
blue and green, respectively. Enlarged views are shown in red
borders. Scale bar, 100 mm.
(TIF)
Figure S2 The expression of GFP derived from NA-
deficient influenza virus overlapped with the localiza-
tion of NP. MDCK cells were infected with NA-deficient
influenza viruses at MOI of 0.0001. After incubation at 37uC for
48 hours, immunofluorescence analyses were performed using
anti-NP antibody. Scale bar, 100 mm.
(TIF)
Figure S3 Influenza virus A/Udorn/72 was sensitive to
oseltamivir. MDCK cells were infected with influenza virus A/
Udorn/72 at a MOI of 0.001 PFU per cell. At 36 hpi, the culture
supernatant was collected, and then its virus titer was determined
by plaque assays. Each result was represented by a value relative to
that in the absence of the drug. Error bars indicate s.d. from 3
independent experiments.
(TIF)
Video S1 NA-deficient influenza virus spreads through
cell-to-cell transmission. Confluent MDCK cells were
infected with NA-deficient influenza virus at MOI of 0.0001 in
the presence of trypsin. After incubation at 37uC for 24 hours, a
single GFP-positive cell and its vicinity were traced it during the
period from 24 hpi to 48 hpi at interval of 1 hour. Live cell
imaging data analyses was performed by Biostation ID (GE
healthcare). Scale bar, 50 mm.
(MOV)
Video S2 NA-deficient influenza virus does not spread
in the absence of trypsin. Confluent MDCK cells were
infected with the NA-deficient influenza virus at MOI of 0.0001 in
the absence of trypsin. After incubation at 37uC for 24 hours, a
single GFP-positive cell was detected, and then this cell and
neighborhood cells was traced during the period from 24 hpi to
48 hpi at interval of 1 hour. Live cell imaging data analyses were
performed by Biostation ID (GE healthcare). Scale bar, 50 mm.
(MOV)
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